Evidence map›Paper›PMID 28525384›Full record

ArticleOncotarget2017

Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth.

Lore Lapeire, An Hendrix, Evelyne Lecoutere, Mieke Van Bockstal, Jo Vandesompele, Dawn Maynard, Geert Braems, Rudy Van Den Broecke, Cathérine Müller, Marc Bracke and 3 more

Abstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lore LapeireDepartment of Medical Oncology, Ghent University Hospital, Ghent, Belgium.
An HendrixCancer Research Institute Ghent (CRIG), Ghent University Hospital, Ghent, Belgium.
Evelyne LecoutereDepartment of Pathology, Ghent University Hospital, Ghent, Belgium.
Mieke Van BockstalDepartment of Pathology, Ghent University Hospital, Ghent, Belgium.
Jo VandesompeleCancer Research Institute Ghent (CRIG), Ghent University Hospital, Ghent, Belgium.
Dawn MaynardMedical Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland, USA.
Geert BraemsDepartment of Gynecology, Ghent University Hospital, Ghent, Belgium.
Rudy Van Den BroeckeDepartment of Gynecology, Ghent University Hospital, Ghent, Belgium.
Cathérine MüllerInstitut de Pharmacologie et de Biologie Structurale, Université de Toulouse, UPS, Toulouse, France.
Marc BrackeLaboratory of Experimental Cancer Research, Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium.
Véronique CocquytDepartment of Medical Oncology, Ghent University Hospital, Ghent, Belgium.
Hannelore DenysDepartment of Medical Oncology, Ghent University Hospital, Ghent, Belgium.
Olivier De WeverCancer Research Institute Ghent (CRIG), Ghent University Hospital, Ghent, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adipose tissue secretes a plethora of adipokines as evidenced by characterization of subcutaneous and visceral adipose tissue secretomes. However, adipose tissue composition and secretion pattern is depot and disease dependent, influencing the adipose tissue secretome. We investigated the secretome of cancer-associated adipose tissue (CAAT) explants from breast cancer patients and explored its role in breast cancer proliferation. CAAT proteins were identified by LC-MS/MS and human protein antibody arrays and stimulated proliferation of three breast cancer cell lines. Kinomics and transcriptomics of MCF-7 breast cancer cells treated with the secretome of CAAT revealed activation of Akt-, ERK- and JNK-pathways and differential expression of activator protein 1 (AP-1) and cAMP responsive element-binding protein (CREB) target genes. The cyclin-dependent kinase (CDK)4/6-inhibitor palbociclib significantly abrogated CAAT-enhanced breast cancer cell proliferation. Our work characterizes the specific breast CAAT protein secretome and reveals its pro-proliferative potency in breast cancer.

Indexed as

MetabolomicsParacrine CommunicationAdipose TissueAntineoplastic AgentsBreast NeoplasmsCell Line, TumorCell ProliferationCyclic AMP Response Element-Binding ProteinFemaleHumansPiperazinesProtein Kinase InhibitorsProteomicsPyridinesTranscription Factor AP-1Antineoplastic AgentsCyclic AMP Response Element-Binding ProteinpalbociclibPiperazinesProtein Kinase InhibitorsPyridinesTranscription Factor AP-1adipose tissuebreast cancerpalbociclibproliferationsecretome

Identifiers

PMID28525384
PMCPMC5564561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.